- Report
- July 2026
- 130 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- August 2026
- 110 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- August 2026
- 115 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- August 2026
- 110 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- August 2026
- 142 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- July 2026
- 135 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- July 2026
- 110 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- July 2026
- 180 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- May 2026
- 350 Pages
Global
From €4552EUR$4,949USD£3,878GBP
- Report
- May 2026
- 350 Pages
Global
From €4552EUR$4,949USD£3,878GBP
- Report
- May 2026
- 400 Pages
Global
From €4552EUR$4,949USD£3,878GBP
- Report
- August 2026
- 148 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- May 2026
- 165 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- January 2026
- 144 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- May 2026
- 156 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- May 2026
- 152 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- May 2026
- 154 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- May 2026
- 150 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- May 2026
- 151 Pages
Global
From €3633EUR$3,950USD£3,095GBP
- Report
- April 2026
- 165 Pages
Global
From €3633EUR$3,950USD£3,095GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more